Antibiotic resistance: where do we go next?
Science Weekly
00:00
The Arms Race Between Antibiotics and the Evolution of Bacteria
Drug development is hugely expensive for drug companies. Governments need to think about how they're going to incentivize companies, says Dr Andrew Hammond. Despite all this, we've seen a couple of interesting developments already this year - one relating to genetically modified bacteria.
Transcript
Play full episode
